NCT06536712View on ClinicalTrials.gov

Effects of Exosome Adminstration in Preventing Early Leakage in Rectal Cancer Patients Undergoing Low Anterior Resection

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Rectal Cancer
Interventions
BIOLOGICAL

Mesenchymal Stem Cells Derived Exosomes

Mesenchymal Stem Cells Derived Exosomes will be administered intraperitoneally to patients at the end of their surgery

OTHER

Placebo

10 patients will receive intraperitoneal placebo at the end of their surgery

Trial Locations (1)

1419733141

Division of Colorectal Surgery, Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT06536712 - Effects of Exosome Adminstration in Preventing Early Leakage in Rectal Cancer Patients Undergoing Low Anterior Resection | Biotech Hunter | Biotech Hunter